Why Snowflake Is Trading Higher By 20%, Here Are 51 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 91% to $0.2530 after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and announced a price target of $6.50.
Why Splunk Is Trading Lower By Around 10%; Here Are 28 Stocks Moving Premarket
Gainers
ECMOHO Limited (NASDAQ: MOHO) shares rose 47% to $0.2149 in pre-market trading.
HC Wainwright & Co. Maintains Buy on Vaccitech, Lowers Price Target to $20
HC Wainwright & Co. analyst Yi Chen maintains Vaccitech (NASDAQ:VACC) with a Buy and lowers the price target from $22 to $20.
Why Is DoorDash Down By 8%? 38 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 69.5% to $2.1199 after the company announced it has developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition.
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Gainers
Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Arbutus And Vaccitech Dose First Patient In Phase 2a Clinical Trial Combining Therapies For The Treatment Of Chronic Hepatitis B Virus
Arbutus Biopharma Corporation (NASDAQ:ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, and Vaccitech plc
Morgan Stanley Maintains Overweight on Vaccitech, Lowers Price Target to $19
Morgan Stanley maintains Vaccitech (NASDAQ:VACC) with a Overweight and lowers the price target from $20 to $19.